TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/21 17:00 | 11/15/21 | CUE | Cue Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Suri Anish | MA | O | P,CSO | S.d | -144 | 18.05 | 0 | -8 | -8 | 94 | D | ||||||||||||||
11/15/21 17:00 | 11/11/21 | CUE | Cue Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Suri Anish | MA | O | P,CSO | S.d | -301 | 15.07 | 0 | -20 | -18 | 94 | D | ||||||||||||||
9/27/21 16:30 | 9/23/21 | CUE | Cue Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Suri Anish | MA | O | P,CSO | S.d | -305 | 15.23 | 0 | -20 | -21 | 75 | D | ||||||||||||||
8/7/20 17:41 | 8/5/20 | CUE | Cue Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Suri Anish | MA | O | P,CSO | S.d | -16 | 20.01 | 0 | -1 | -2 | 35 | D | ||||||||||||||
8/5/20 16:50 | 8/3/20 | CUE | Cue Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Suri Anish | MA | O | P,CSO | S.dm | -124 | 20.02 | 0 | -6 | -15 | 35 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |